CASI Pharmaceuticals, Inc. (CASI)

USD 1.95

(-2.01%)

Annual Balance Sheets

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 75.26 Million 96.23 Million 138.29 Million 127.73 Million 102.63 Million 113.41 Million
Total Current Assets 59.34 Million 73.42 Million 61.97 Million 74.02 Million 61.5 Million 92.56 Million
Cash And Short Term Investments 30.76 Million 51.33 Million 48.57 Million 66.37 Million 54.24 Million 85.11 Million
Cash and Cash Equivalents 17.08 Million 47.11 Million 38.7 Million 57.06 Million 53.62 Million 84.2 Million
Short Term Investments 13.68 Million 4.22 Million 9.86 Million 9.3 Million 625 Thousand 912.2 Thousand
Net Receivables 10.13 Million 12.97 Million 9.8 Million 4.64 Million 1.29 Million 1.00
Inventory 15.87 Million 6.13 Million 1.9 Million 1.35 Million 4.54 Million 283 Thousand
Other Current Assets 2.56 Million 2.97 Million 1.68 Million 1.65 Million 1.42 Million 7.44 Million
Total Non-Current Assets 15.92 Million 22.81 Million 76.32 Million 53.7 Million 41.13 Million 20.84 Million
Net PPE 11.63 Million 13.22 Million 21.81 Million 10.75 Million 9.69 Million 1.75 Million
Good Will And Intangible Assets 1.83 Million 1.06 Million 12.2 Million 13.21 Million 16.89 Million 18.78 Million
Good Will - - - - - -
Intangible Assets 1.83 Million 1.06 Million 12.2 Million 13.21 Million 16.89 Million 18.78 Million
Long-Term Investments 1.68 Million 7.46 Million 40.12 Million 29.44 Million 14.03 Million -
Tax Assets - - - - - -
Other Non Current Assets 766 Thousand 1.05 Million 2.17 Million 299 Thousand 504 Thousand 310.02 Thousand
Other Assets - - - - - -
Total Liabilities 51.1 Million 29.3 Million 30.33 Million 24.16 Million 8.96 Million 3.94 Million
Total Current Liabilities 16.72 Million 17 Million 13.18 Million 7.97 Million 7.94 Million 3.87 Million
Account Payables 4.43 Million 3.28 Million 4.78 Million 3.66 Million 5.11 Million 968.04 Thousand
Tax Payables 481 Thousand 2.05 Million 652 Thousand 434 Thousand - -
Short Term Debt 728 Thousand 868 Thousand 1.06 Million 1.29 Million 1.18 Million 1.49 Million
Deferred Revenue 2.54 Million 2.61 Million 2.82 Million 2.35 Million - -
Other Current Liabilities 9.01 Million 10.23 Million 4.5 Million 664 Thousand 1.65 Million 1.4 Million
Total Non Current Liabilities 34.37 Million 12.29 Million 17.15 Million 16.18 Million 1.01 Million 73.59 Thousand
Long-Term Debt 18.89 Million 476 Thousand 1.1 Million 965 Thousand 1.01 Million -
Deferred Revenue Non Current - - 2.82 Million 2.35 Million - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 15.48 Million 11.82 Million 13.22 Million 13.83 Million - 73.59 Thousand
Other Liabilities - - - - - -
Total Equity 24.16 Million 66.93 Million 107.95 Million 103.57 Million 93.66 Million 109.46 Million
Stock Holders Equity 24.16 Million 44.57 Million 84.5 Million 81.54 Million 72.99 Million 109.46 Million
Common Stock 1000.00 1000.00 1.39 Million 1.24 Million 979 Thousand 953.66 Thousand
Retained Earnings -660.81 Million -637.16 Million -605.64 Million -570.5 Million -523.9 Million -478.94 Million
Accumulated other comprehensive income -1.2 Million -703 Thousand 1.95 Million 589 Thousand -2.72 Million -1.22 Million
Common Stock Equity 24.16 Million 44.57 Million 84.5 Million 81.54 Million 72.99 Million 109.46 Million
Capital Lease Obligation 1.61 Million 1.34 Million 2.16 Million 965 Thousand 2.2 Million -
Total Investments 15.37 Million 11.68 Million 49.99 Million 38.75 Million 14.66 Million 912.2 Thousand
Total Debt 21.23 Million 1.34 Million 2.16 Million 1.29 Million 2.2 Million 1.49 Million
Net Debt 4.15 Million -45.76 Million -36.53 Million -55.77 Million -51.42 Million -82.7 Million

Balance Sheet Charts